Literature DB >> 12945972

Nontumor integral dose variation in conventional radiotherapy treatment planning.

Warren D D'Souza1, Isaac I Rosen.   

Abstract

Treatment planning involves selecting delivery parameters that distribute the dose to nontumor tissue in such a way as to minimize the risk of complications. This work studied the relationship between nontumor integral dose (NTID), the fractional energy deposited in nontumor tissue, and a variety of delivery parameters for three clinical cases: nasopharynx, pancreas, and prostate. Integral dose for an organ of uniform density is simply the product of the organ density, volume, and mean dose. For each case, conventional plans were generated with 2, 4, 8, 12 and 36 equally spaced beams. All plans were normalized to the same tumor mean dose (< 3%), which is equivalent to the same tumor integral dose. For the pancreas and prostate cases, the patients were assumed to be uniform density. For the nasopharynx case, bones and air cavities were outlined and each assigned a uniform non-unit density. With four or more beams and clinical margin values, the variation in NTID was < 1% as a function of number of beams. With eight or more beams, the variation was < 0.2%. Reducing the beam margin decreased the NTID because less normal tissue was irradiated. However, the effect of the number of beams on NTID was independent of margin size. Higher energy beams reduced the NTID, as expected, and the effect was independent of the number of beams. With four or more beams, variation in beam direction changed NTID by less than 1.5%. Changing beam weights changed NTID by < 2% for plans with four to eight beams. For the body sites studied, the majority of energy was deposited in nontumor tissue, ranging from 72% in the nasopharynx case to 97% for the prostate case. The NTID decreased with increasing tumor size for similar anatomic sizes and increased with increasing size of anatomical region for similar tumor size. Finally, the effect of heterogeneity-corrected doses on the NTID was found to be < 3% for the nasopharynx case. These data support the hypothesis that the NTID is approximately independent of beam orientation or relative weighting when many beams are used. Optimization, therefore, can only find the best distribution of dose; it cannot reduce the energy imparted. NTID may be useful in establishing an upper bound on the quality of plan that can be achieved by optimization.

Entities:  

Mesh:

Year:  2003        PMID: 12945972     DOI: 10.1118/1.1591991

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  29 in total

1.  High-precision radiotherapy for craniospinal irradiation: evaluation of three-dimensional conformal radiotherapy, intensity-modulated radiation therapy and helical TomoTherapy.

Authors:  D S Sharma; T Gupta; R Jalali; Z Master; R D Phurailatpam; R Sarin
Journal:  Br J Radiol       Date:  2009-07-06       Impact factor: 3.039

2.  Validation of a biomarker tool capable of measuring the absorbed dose soon after exposure to ionizing radiation.

Authors:  Anna Giovanetti; Raffaella Marconi; Noha Awad; Hala Abuzied; Neveen Agamy; Mohamed Barakat; Cecilia Bartoleschi; Gianluca Bossi; Marco Canfora; Amr A Elsaid; Laura Ioannilli; Horeya M Ismail; Yasmine Amr Issa; Flavia Novelli; Maria Chiara Pardini; Claudio Pioli; Paola Pinnarò; Giuseppe Sanguineti; Mohamed M Tahoun; Riccardo Turchi; Lidia Strigari
Journal:  Sci Rep       Date:  2021-04-14       Impact factor: 4.379

3.  Dosimetric influence of filtered and flattening filter free photon beam on rapid arc (RA) radiotherapy planning in case of cervix carcinoma.

Authors:  Lalit Kumar; Girigesh Yadav; Kothanda Raman Samuvel; Manindra Bhushan; Pawan Kumar; Mahammood Suhail; Manoj Pal
Journal:  Rep Pract Oncol Radiother       Date:  2016-10-17

4.  Influence of optimizing protocol choice on the integral dose value in prostate radiotherapy planning by dynamic techniques - Pilot study.

Authors:  Anna Zaleska; Krzysztof Bogaczyk; Tomasz Piotrowski
Journal:  Rep Pract Oncol Radiother       Date:  2017-08-17

Review 5.  Recent advancements in multimodality treatment of gliomas.

Authors:  Mersiha Hadziahmetovic; Katsuyuki Shirai; Arnab Chakravarti
Journal:  Future Oncol       Date:  2011-10       Impact factor: 3.404

6.  New approach in lung cancer radiotherapy offers better normal tissue sparing.

Authors:  Ivaylo B Mihaylov
Journal:  Radiother Oncol       Date:  2016-09-28       Impact factor: 6.280

Review 7.  A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction.

Authors:  X George Xu; Bryan Bednarz; Harald Paganetti
Journal:  Phys Med Biol       Date:  2008-06-09       Impact factor: 3.609

8.  Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma : A dosimetric comparison.

Authors:  S Adeberg; S B Harrabi; N Bougatf; D Bernhardt; J Rieber; S A Koerber; M Syed; T Sprave; A Mohr; A Abdollahi; T Haberer; S E Combs; K Herfarth; J Debus; S Rieken
Journal:  Strahlenther Onkol       Date:  2016-06-22       Impact factor: 3.621

9.  A dosimetric analysis of 6 MV versus 15 MV photon energy plans for intensity modulated radiation therapy (IMRT) of carcinoma of cervix.

Authors:  Atul Tyagi; Sanjay S Supe; Man P Singh
Journal:  Rep Pract Oncol Radiother       Date:  2010-09-22

10.  Static versus dynamic intensity-modulated radiotherapy: Profile of integral dose in carcinoma of the nasopharynx.

Authors:  K S Jothybasu; Amit Bahl; V Subramani; G K Rath; D N Sharma; P K Julka
Journal:  J Med Phys       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.